The role of hematopoietic cell transplantation (HCT) in the management of newly diagnosed
adult acute myeloid leukemia (AML) is reviewed and critically evaluated in this evidence …

Recipients of allogeneic stem cell transplantation (alloSCT) are at risk for reactivation of
endogenous herpesviruses due to profound and prolonged T cell deficiency following …

The success of hematopoietic stem cell transplantation (HSCT) with reduced-intensity
conditioning (RIC) is limited by a high rate of disease relapse. Early risk assessment could …

The standard regimens for graft-versus-host disease (GvHD) prophylaxis in matched
unrelated donor (MUD) transplantation were based on antithymocyte globulin (ATG) in …

Nowadays, the most wildly used regimens for graft-versus-host disease (GvHD) prophylaxis
in haplo-hematopoietic stem cell transplantation (Haplo-HSCT) are based on in vivo T-cell …

Maternal and collateral donors were associated with a higher incidence of graft-versus-host
disease (GvHD) after haploidentical hematopoietic stem cell transplantation (haplo-HSCT) …

Reduced-intensity conditioning (RIC) has offered many primary immunodeficiency disorder
(PID) patients who are ineligible for myeloablative regimens a chance of cure. However, the …

The best donors for hematopoietic SCT (HSCT) are fully-matched siblings. In patients
without fully-matched siblings, HLA registries or cord blood banks are alternative strategies …

Double umbilical cord blood (dUCB) allogeneic transplantation after a low-dose total body
irradiation, cyclophosphamide, and fludarabine (TCF)–based reduced-intensity conditioning …

A conditioning regimen with fludarabine and myeloablative dose of busulfan (FLU/BU4) has
been commonly used in allogeneic hematopoietic cell transplantation (allo-HCT). However …